Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02728401 · ClinicalTrials.gov registry record
Genotypes and Phenotypes in Pediatric SIRS and Sepsis
A clinical trial, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- 104
- Enrollment target
NCT02728401: Completed study, sponsored by Seattle Children's Hospital.
NCT02728401 is a clinical trial that has completed, run by Seattle Children's Hospital. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02728401 has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
The aim of this investigation is to longitudinally quantify host gene expression and serum proteins in children with infectious and non-infectious SIRS. The investigators hypothesize that children with non-infectious SIRS, with bacterial infection associated SIRS, or with viral infection associated SIRS will exhibit distinct patterns of host gene expression and serum proteins. The investigators further hypothesize that it should be possible to discover sets of mRNA or protein biomarkers that will permit unambiguous diagnosis of non-infectious SIRS, SIRS associated with bacterial infection, and SIRS associated with viral infection.
Primary Outcome
Gene expression levels (quantitative) will be compared between CSSS, INSI and viral infection groups, in a search for signatures that can discriminate these groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2013-05-01 |
| Est. Completion | 2017-12-31 |
What the finished NCT02728401 record still lists
NCT02728401 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02728401 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02728401 about?
NCT02728401 is a clinical study titled "Genotypes and Phenotypes in Pediatric SIRS and Sepsis". The aim of this investigation is to longitudinally quantify host gene expression and serum proteins in children with infectious and non-infectious SIRS. The investigators hypothesize that children with non-infectious SIRS, with bacterial infection associated SIRS, or with viral infection associated ...
What is the current status of trial NCT02728401?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2013-05-01. Estimated completion is 2017-12-31.
Who is sponsoring clinical trial NCT02728401?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI